0.00Open18.02Pre Close0 Volume2 Open Interest118.00Strike Price0.00Turnover0.00%IV5.70%PremiumDec 13, 2024Expiry Date11.98Intrinsic Value100Multiplier0DDays to Expiry6.04Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma8.76Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Novo-Nordisk A/S Stock Discussion
FLOW trial evaluated the risk reduction associated with treatment with Ozempic ® in chronic kidney disease-related events in adults with type 2 diabetes and chronic kidney disease (CKD). FLOW, semag...
The agreement The acquisition of the three production sites was announced on February 5. On May 29, Catalent shareholders voted in favor of the pending transac...
$Novo-Nordisk A/S (NVO.US)$
new
for some reason the profile says its lly
it's so greeen
Add...
No comment yet